$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Research progress on the possibility of capmatinib (Touradida) treating other types of cancer
2026-02-01 22:25:32
Check Details
Analysis of the differences in treatment strategies between sotoracib (AMG 510) and osimertinib
2026-02-01 22:25:32
Check Details
Study results on whether adagrasib (Krazati) needs to be combined with other drugs
2026-02-01 22:25:32
Check Details
Detailed description of Pimitespib’s launch time and drug purchasing channels in China
2026-02-01 22:25:32
Check Details
The latest price and medical insurance reference information of Afatinib in 2025
2026-02-01 22:25:32
Check Details
Clinical efficacy and evaluation of the treatment of insomnia with DaliRasheng (Keweike)
2026-02-01 22:25:32
Check Details
Instructions on whether the drug can be stopped at will after long-term use of Lynparza
2026-02-01 22:25:32
Check Details
Detailed explanation of whether Venetoclax has been included in medical insurance and reimbursement policy
2026-02-01 22:25:32
Check Details
Asciminib China listing status and official approval information
2026-02-01 22:25:32
Check Details
Will ritexitinib (Lefenox) affect menstruation and precautions for female medication?
2026-02-01 22:25:32
Check Details
Analysis of Spasentan (Sparsentan) imported drug price and purchasing reference information
2026-02-01 22:25:32
Check Details
Can ixazomib (Enleri) be used in combination with dexamethasone and precautions
2026-02-01 22:25:32
Check Details
1
2
...
2152
2153
2154
2155
2156
2157
2158
...
10227
10228
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tivozanib Dosage and Administration: Standard Dosing, Cycle Schedule, and Hepatic Impairment Adjustments
2
Long-Term Anagrelide Use: Common Adverse Effects and Key Monitoring Considerations
3
Resmetirom Indication Clarification: Approved for NASH Fibrosis, Not Hepatitis B Cirrhosis
4
Vemurafenib: Mechanism of Action and Clinical Role in BRAF V600E–Targeted Therapy
5
Anagrelide vs. Hydroxyurea in Essential Thrombocythemia: Efficacy Profiles and Clinical Positioning
6
SCEMBLIX (Asciminib) Side Effect Management & Special Population Guide
7
Sabril (Vigabatrin) Explained: Indications, Vision Loss Risk & Key Warnings
8
FDA Approves Tauklarify for Tau PET Imaging in Alzheimer's Disease Assessment
9
First CELMoD Drug Zenbexus Wins FDA Accelerated Approval for Multiple Myeloma
10
Elamipretide Side Effects and Medication Safety Guide: Injection Site Reactions and Storage Essentials
11
Dutasteride Soft Capsules: Comprehensive Side Effect Profile and Management Strategies
12
Oral Semaglutide Tablets: A Complete Guide to the GLP-1 Receptor Agonist for Type 2 Diabetes and Cardiovascular Protection